Investment Summary |
|
|---|---|
| Date | 2022-02-10 |
| Target | Rockland |
| Sector | Life Science |
| Investor(s) | The BroadOak Fund |
| Deal Type | Growth Capital |
SEARCH BY
The BroadOak Fund is the investment affiliate of life science focused investment bank BroadOak Capital Partners. The BroadOak Fund provides growth capital to life sciences tools and service providers that have achieved a level of commercial success. The BroadOak Fund is based in Bethesda, Maryland.
| DEAL STATS | # |
|---|---|
| Overall | 18 of 26 |
| Sector: Life Science M&A | 15 of 21 |
| Type: Growth Capital M&A Deals | 8 of 14 |
| State: Pennsylvania M&A | 1 of 2 |
| Country: United States M&A | 17 of 24 |
| Year: 2022 M&A | 2 of 7 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-01-18 |
PhenoVista Biosciences
San Diego, California, United States PhenoVista Biosciences is a CRO specializing in modern human cell-based in vitro assay development and analysis. PhenoVista Biosciences was founded in 2014 and is based in San Diego, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-05-12 |
Biolog
Hayward, California, United States Biolog engages in microbial identification, phenotypic cell profiling, and metabolic fingerprinting for microbial and mammalian cells. The company’s products enable the identification of thousands of species of bacteria, yeast, and fungi as well as characterization of human cells and mitochondria. Biolog products are available worldwide, either directly from the company or through its extensive network of international distributors. Biolog is based in Hayward, California. |
Buy | - |
